Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19) pandemic and is continuously spreading globally. The continuous emergence of new SARS-CoV-2 variants keeps posing threats, highlighting the need for fast-acting, mutation-resistant broad-s...
Saved in:
| Main Authors: | Shan-Na Wu, Ting Xiao, Hui Chen, Xiao-Hong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | RNA Biology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15476286.2024.2433830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calceolarioside B inhibits SARS-CoV-2 Omicron BA.2 variant cell entry and modulates immune response
by: Xiao-bin Lin, et al.
Published: (2024-12-01) -
Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq
by: Ahmed A. Al-Mankhee, et al.
Published: (2024-11-01) -
Identification of the Selenoprotein S Positive UGA Recoding (SPUR) element and its position-dependent activity
by: Eric M. Cockman, et al.
Published: (2024-12-01) -
Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01) -
Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh
by: L. Carnegie, et al.
Published: (2024-11-01)